HomeTolcaponeTolcapone + Phenytoin

Does Tolcapone Interact with Phenytoin?

Tolcapone and Phenytoin have a minor drug interaction according to U.S. FDA drug labeling data. In vitro protein binding studies showed tolcapone did not displace phenytoin from binding sites at therapeutic concentrations. The mechanism involves protein binding interaction (no clinically relevant effect demonstrated). Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Tolcapone Class
Catechol-O-Methyltransferase Inhibitor
Phenytoin Class
Anti-epileptic Agent
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Tolcapone and Phenytoin occurs because protein binding interaction (no clinically relevant effect demonstrated). Clinically, this means in vitro protein binding studies showed tolcapone did not displace phenytoin from binding sites at therapeutic concentrations. This is classified as a minor interaction with generally low clinical significance, though your healthcare provider should still be informed that you are taking both medications.

What To Tell Your Doctor or Pharmacist

If you are taking Tolcapone and your doctor is considering prescribing Phenytoin (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tolcapone(Tolcapone)+💊 Phenytoin(Phenytoin Infatabs)

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Catechol-O-Methyltransferase Inhibitor
Drug B class
Anti-epileptic Agent
Source
NLP:tolcapone

What this means in plain English

In vitro protein binding studies showed tolcapone did not displace phenytoin from binding sites at therapeutic concentrations.

What the FDA label says

"Protein binding interaction (no clinically relevant effect demonstrated)"

📖 Source: NLP:tolcapone

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Tolcapone and Phenytoin against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.